default author photo

Yoonhee Choi

NewYork-Presbyterian Hospital

SCHOLARLY PAPERS

1

DOWNLOADS

110

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Durable Complete Response in Leptomeningeal Disease (Lmd) of Egfr Mutated Non-Small Cell Lung Cancer (Nsclc) to Amivantamab, an Egfr-Met Receptor Bispecific Antibody, after Progressing on Osimertinib

Number of pages: 14 Posted: 09 Aug 2023
University of Pittsburgh, University of Hawaii, University of Hawaii, Northwestern University - Feinberg School of Medicine, NewYork-Presbyterian Hospital, Northwestern University - Feinberg School of Medicine, Northwestern University - Northwestern Memorial Hospital and Northwestern University - Northwestern Memorial Hospital
Downloads 110 (640,165)

Abstract:

Loading...

Amivantamab, monotherapy, rare EGFR mutation, NSCLC, case report